Related Experiment Video
Updated: Aug 11, 2025
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
459
Helicobacter pylori treatment knowledge, access and barriers: A cross-sectional study
Kimberly S Bailey1, Heidi E Brown1, Viktor Lekic2
1Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Helicobacter
|February 7, 2023
Summary
Helicobacter pylori (Hp) knowledge is low in the US, with many patients not completing treatment. Increasing awareness and addressing treatment barriers could reduce gastric cancer risks.
Area of Science:
- Medical Microbiology
- Gastroenterology
- Public Health
Background:
- Helicobacter pylori (Hp) is a prevalent bacterial infection globally and a significant risk factor for gastric cancer (GC).
- Disparities in Hp infection rates and related diseases exist within the United States.
- Understanding Hp infection is crucial as it is treatable and knowledge influences health-seeking behaviors.
Purpose of the Study:
- To assess the baseline knowledge of Helicobacter pylori (Hp) among US adults.
- To identify barriers to seeking and adhering to Hp care.
Main Methods:
- A cross-sectional study was conducted with 1042 participants recruited via the Amazon MTurk online platform.
- Data collected included self-reported knowledge of Hp, personal or family history of Hp diagnosis, and experiences with treatment.
Main Results:
- Over half of respondents (52.3%) had prior Hp knowledge; 11.7% reported personal treatment, and 21.4% reported family diagnoses.
- Among those treated, 78% experienced gastrointestinal upset, and 21% did not complete prescribed medications.
- Beliefs about treatment severity (70%) and knowledge of Hp causing GC (81%) significantly influenced willingness to seek or continue care.
Conclusions:
- Low awareness of Helicobacter pylori (Hp) and high rates of self-reported treatment non-compliance were observed in this US online sample.
- Enhancing public awareness of Hp and overcoming treatment adherence challenges can potentially decrease antibiotic resistance and prevent GC progression.
More Related Videos
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
498
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
498
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
171
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
171
01:26Peptic Ulcer Disease IV: Management
127
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
127
01:28Peptic Ulcer Disease II: Pathophysiology
649
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
649
01:23Gastritis III: Clinical Manifestations and Management
377
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
377
01:30Peptic Ulcer Disease I: Introduction
244
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
244